Show an ad over header. AMP

Scientists are trying to figure out how much the amount of coronavirus in your body matters

How sick a person gets from a virus can depend onhow much of the pathogen that person was exposed to and how much virus is replicating in their body — questionsthat are still open for the novel coronavirus.

Why it matters: As people try to balance resuming parts of their daily lives with controlling their risk of COVID-19, understanding the role of viral load could help tailor public health measures and patient care.


Driving the news: An analysis of 5,000 genomic sequences of the coronavirus from patients found those infected with a now-dominant strain with a specific mutation "had higher loads of virus in their upper respiratory tracts, a potential factor in making the strain spread more effectively," the Washington Post reports.

  • Viruses typically mutate as they spread through a population, and the mutation that is accumulating wasn't linked to the virus becoming deadlier, according to the study, which hasn't yetbeen peer-reviewed.
  • But the research underscores open questions about COVID-19: How does the amount of virus in someone affect transmission to others, and theseverity of the disease?

How it works: Viral dose is how much virus someone is exposed to when they are infected. Viral load is the amount of virus produced in someone's body after they are infected.

  • A higher infectious dose of a virus and a higher viral load is linked to more severe disease from influenza, poxviruses and other viruses.

For SARS-CoV-2, the virus that causes COVID-19, "there's accumulating data on both sides of the equation," Monica Gandhi, a professor of medicine and an infectious disease doctor at UCSF, tells Axios.

  • In a study of Syrian hamsters, for example, those infected with a higher dose of SARS-CoV-2 had worse outcomes than those with smaller amounts, supporting an earlier study on hamsters checking if "masks" helped prevent transmission, she points out.
  • Outbreak investigations show that where there's universal masking of a population, the severity of disease goes down.
  • Some researchers suggest a decline in death rate and the rise in asymptomatic cases in the U.S. this summer — both coming at a time when mask-wearing became more common — indicate reducing the dose of the virus may reduce the severity of disease.

"It's very interesting that it seems like it's correlating with masking, this lower rate of severe illness," says Gandhi, adding that the hypothesis remains unproven but has some growing evidence behind it.

  • She co-authored a perspective piece in the NEJM this week that says universal adoption of masks could reduce infections and severity until an effective vaccine is distributed.
  • Last week, CDC director Robert Redfield suggested face masks are "more guaranteed" to offer protection against the coronavirus than a potential vaccine.

What's happening: Evidence is emergingabout the link between viral load and how severe COVID-19 is for a patient.

  • In a study of more than 3,000 patients in three New York City hospitals, nearly 40% who tested positive for COVID-19 and had a high viral load died in the hospital.
  • But the risk of dying was lower — dropping to about 15% — for patients with a low viral load, Michael Satlin, an infectious disease specialist at Weill Cornell Medicine and NewYork-Presbyterian, and colleagues reported last week in the journal Cancer Cell.
  • Of note: The study was done at the height of the city's outbreak in the spring, and Satlin says that given improvements in caring for patients with COVID-19, he wouldn't expect to see such high mortality rates today.
  • And the amount of virus the patients were exposed to or their viral load when symptoms started wasn't known — connecting those dots will require more testing, he adds.

Yes, but: Other studies have also found some people without symptoms can have viral loads similar to those with symptoms. And children, who tend to be spared severe COVID-19 complications, can carry as much or more of the virus in their upper respiratory tract.

  • "Viral load is a part of the picture, but it's not the full picture," infectious disease specialist Ravina Kullar told MedPage Today, adding that disease severity depends on a person's immune system.

What to watch: Knowing a patient's viral load could be helpful to providers indetermining how therapies should be directed.

  • Viral load information is in the PCR tests done to confirm SARS-CoV-2 infection but the tests aren't approved by the FDA for that quantitative information, Satlin says.
  • If it could be released to clinicians, "it could be very useful" for determining care for people who are hospitalized, he adds.

Go deeper: Where the science stands on using face masks against coronavirus

Salesforce rolls the dice with likely acquisition of Slack

Salesforce's likely acquisition of workplace messaging service Slack — not yet a done deal but widely anticipated to be announced Tuesday afternoon — represents a big gamble for everyone involved.

For Slack, challenged by competition from Microsoft, the bet is that a deeper-pocketed owner like Salesforce, with wide experience selling into large companies, will help the bottom line.

Keep reading... Show less

Eleven border cities have combined a violent crime rate below the national average

Data: FBI, Kansas Bureau of Investigation; Note: This table includes the eight largest communities on the U.S.-Mexico border and eight other U.S. cities similar in population size and demographics; Chart: Naema Ahmed/Axios

U.S. communities along the Mexico border are among the safest in America, with some border cities holding crime rates well below the national average, FBI statistics show.

Why it matters: The latest crime data collected by the FBI from 2019 contradicts the narrative by President Trump and others that the U.S.-Mexico border is a "lawless" region suffering from violence and mayhem.

Keep reading... Show less

The rise of military space powers

Nations around the world are shoring up their defensive and offensive capabilities in space — for today's wars and tomorrow's.

Why it matters: Using space as a warfighting domain opens up new avenues for technologically advanced nations to dominate their enemies. But it can also make those countries more vulnerable to attack in novelways.

Keep reading... Show less

Governors in the vaccine hot seat

Governors are preparing to face one of the toughest moral choices they'll confront in office: how to allocate limited stocks of coronavirus vaccine among outsized shares of vulnerable Americans.

Why it matters: Everyone agrees health care workers need to be at the front of the line. But after that things get tricky, as New Mexico's Gov. Michelle Lujan Grisham explained in an interview with Axios.

Keep reading... Show less

Slavery ancestorial project to use crowdsourcing in expansion

A database that gathers records about the lives of enslaved Africans and their descendants is undergoing a massive, crowdsourcing-powered expansion to unlock Black Americans' genealogical histories, organizers tell Axios.

Why it matters: The initiative to be unveiled today by Enslaved.org is the latest to reconstruct lost or incomplete timelines and records from the 1600s-1800s, as the U.S. and other nations reckon with systemic racism.

Keep reading... Show less

Scoop: FDA chief called to West Wing

White House Chief of Staff Mark Meadows has summoned FDA commissioner Stephen Hahn to the West Wing for a 9:30am meeting Tuesday to explain why he hasn't moved faster to approve the Pfizer coronavirus vaccine, two senior administration officials told Axios.

Why it matters: The meeting is shaping up to be tense, with Hahn using what the White House will likely view as kamikaze language in a preemptive statement to Axios: "Let me be clear — our career scientists have to make the decision and they will take the time that’s needed to make the right call on this important decision."

Keep reading... Show less

Scoop: Schumer's regrets

Chuck Schumer told party donors during recent calls that the death of Ruth Bader Ginsburg and the fact that Cal Cunningham "couldn’t keep his zipper up” crushed Democrats' chances of regaining the Senate, sources with direct knowledge of the conversations tell Axios.

Why it matters: Democrats are hoping for a 50-50 split by winning two upcoming special elections in Georgia. But their best chance for an outright Senate majority ended when Cunningham lost in North Carolina and Sen. Susan Collins won in Maine.

Keep reading... Show less

Trump's COVID-19 adviser Scott Atlas resigns

Scott Atlas, a controversial member of the White House coronavirus task force, handed in his resignation on Monday, according to three administration officials who discussed Atlas' resignation with Axios.

Why it matters: President Trump brought in Atlas as a counterpoint to NIAID director Anthony Fauci, whose warnings about the pandemic were dismissed by the Trump administration. With Trump now fixated on conspiracy theories about election fraud, Atlas' detail comes to a natural end.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories